The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4194-4201

  Chen, Hui Wen ^a,c   King, Kevin ^a   Tu, Jui ^a   Sanchez, Marisa ^a   Luster, Andrew D ^b   Shresta, Sujan ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; VIRUS RNA;

ALPHA2 INTERFERON GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CXC110 GENE; CYTOKINE RESPONSE; DENGUE; GENE; GENE INDUCTION; INFECTION CONTROL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION; WILD TYPE;

AEDES; ANIMALS; CARRIER PROTEINS; CELL LINE; CHEMOKINE CXCL10; DENGUE; DENGUE VIRUS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYXOVIRUS RESISTANCE PROTEINS; PROTEINS; RECEPTORS, CXCR3; RNA, VIRAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84885463949     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300799     Document Type: Article

References (25)

1. Guzman, M. G., S. B. Halstead, H. Artsob, P. Buchy, J. Farrar, D. J. Gubler, E. Hunsperger, A. Kroeger, H. S. Margolis, E. Martínez, et al. 2010. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8(Suppl): S7-S16.
2. Deen, J. L., E. Harris, B. Wills, A. Balmaseda, S. N. Hammond, C. Rocha, N. M. Dung, N. T. Hung, T. T. Hien, and J. J. Farrar. 2006. The WHO dengue classification and case definitions: time for a reassessment. Lancet 368: 170-173.
3. Julander, J. G., S. T. Perry, and S. Shresta. 2011. Important advances in the field of anti-dengue virus research. Antivir. Chem. Chemother. 21: 105-116.
4. Shresta, S., J. L. Kyle, H. M. Snider, M. Basavapatna, P. R. Beatty, and E. Harris. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T-And B-cell-dependent immunity are less critical. J. Virol. 78: 2701-2710.
5. Prestwood, T. R., M. M. Morar, R. M. Zellweger, R. Miller, M. M. May, L. E. Yauch, S. M. Lada, and S. Shresta. 2012. Gamma interferon (IFN-g) receptor restricts systemic dengue virus replication and prevents paralysis in IFNa/ b receptor-deficient mice. J. Virol. 86: 12561-12570.
6. Zellweger, R. M., T. R. Prestwood, and S. Shresta. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128-139.
7. Shresta, S., K. L. Sharar, D. M. Prigozhin, P. R. Beatty, and E. Harris. 2006. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80: 10208-10217.
8. Shresta, S., K. L. Sharar, D. M. Prigozhin, H. M. Snider, P. R. Beatty, and E. Harris. 2005. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 175: 3946-3954.
9. Perry, S. T., M. D. Buck, S. M. Lada, C. Schindler, and S. Shresta. 2011. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 7: e1001297.
10. Perry, S. T., T. R. Prestwood, S. M. Lada, C. A. Benedict, and S. Shresta. 2009. Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J. Virol. 83: 8276-8281.
11. Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, and M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNAviruses in innate immunity. J. Virol. 82: 335-345.
12. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Tolllike receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
13. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47.
14. Yauch, L. E., R. M. Zellweger, M. F. Kotturi, A. Qutubuddin, J. Sidney, B. Peters, T. R. Prestwood, A. Sette, and S. Shresta. 2009. A protective role for dengue virus-specific CD8+ T cells. J. Immunol. 182: 4865-4873.
15. Daffis, S., M. A. Samuel, B. C. Keller, M. Gale, Jr., and M. S. Diamond. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and-independent mechanisms. PLoS Pathog. 3: e106.
16. Uppaluri, R., K. C. Sheehan, L. Wang, J. D. Bui, J. J. Brotman, B. Lu, C. Gerard, W. W. Hancock, and R. D. Schreiber. 2008. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 86: 137-147.
17. Khan, I. A., J. A. MacLean, F. S. Lee, L. Casciotti, E. DeHaan, J. D. Schwartzman, and A. D. Luster. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
18. Prestwood, T. R., M. M. May, E. M. Plummer, M. M. Morar, L. E. Yauch, and S. Shresta. 2012. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J. Virol. 86: 12138-12147.
19. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
20. Daffis, S., M. A. Samuel, M. S. Suthar, B. C. Keller, M. Gale, Jr., and M. S. Diamond. 2008. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 82: 8465-8475.
21. Hsieh, M. F., S. L. Lai, J. P. Chen, J. M. Sung, Y. L. Lin, B. A. Wu-Hsieh, C. Gerard, A. Luster, and F. Liao. 2006. Both CXCR3 and CXCL10/IFNinducible protein 10 are required for resistance to primary infection by dengue virus. J. Immunol. 177: 1855-1863.
22. Maloney, N. S., L. B. Thackray, G. Goel, S. Hwang, E. Duan, P. Vachharajani, R. Xavier, and H. W. Virgin. 2012. Essential cell-Autonomous role for interferon (IFN) regulatory factor 1 in IFN-g-mediated inhibition of norovirus replication in macrophages. J. Virol. 86: 12655-12664.
23. Rudd, P. A., J. Wilson, J. Gardner, T. Larcher, C. Babarit, T. T. Le, I. Anraku, Y. Kumagai, Y. M. Loo, M. Gale, Jr., et al. 2012. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J. Virol. 86: 9888-9898.
24. Daffis, S., M. S. Suthar, K. J. Szretter, M. Gale, Jr., and M. S. Diamond. 2009. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 5: e1000607.
25. Lazear, H. M., A. Lancaster, C. Wilkins, M. S. Suthar, A. Huang, S. C. Vick, L. Clepper, L. Thackray, M. M. Brassil, H. W. Virgin, et al. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9: e1003118.